Critical Illness Clinical Trial
Official title:
A Multicomponent Intervention to Reduce Perceived Discomforts in Critically Ill Patients: a Randomized Controlled Trial
Since critically ill patients are exposed to stressful conditions, the investigators evaluated the effectiveness of a multicomponent program to reduce perceived discomforts in the Intensive Care Unit (ICU) .
The investigators conducted a cluster-randomized trial randomizing 34 ICUs. The program
targeted staff members with 3 components : web-based systematic measurement of discomforts
on the day of ICU discharge by institutional caregivers (nurses and assistant nurses of the
participating ICU), immediate feedback through electronic reminder messages intended to
caregivers, and targeted interventions in each ICU based on comparative discomfort scores
monthly reported to local champions who were also responsible for staff education.
The measurement of discomforts perceived by critically ill patients at the end of the ICU
stay, related to the whole stay in the ICU, was performed by the bedside nurse using a
specific questionnaire, the IPREA questionnaire whose construct validity, external validity,
reliability, reproducibility and acceptability have been already demonstrated (Development
and validation of a questionnaire for quantitative assessment of perceived discomforts in
critically ill patients. Kalfon P et al, Intensive care Med 2010, 36:1751-58). The version
of the IPREA questionnaire used in the study was a 18-item questionnaire : noise ; excessive
light ; discomfort related to sleeping in a different bed from home ; sleep deprivation ;
thirst ; hunger ; feeling of cold ; feeling of heat ; pain ; being tied down by perfusion
lines, tubes or as a result of connections due to monitoring devices ; no respect for
intimacy ; anxiety ; isolation ; limited visiting hours ; absence of phone ; lack of
information ; shortness of breath ; and depression.
The duration of the program is 6 months in each arm. Potential participants in the study
were consecutive patients admitted in all the participating ICU that are divided in two
groups of 17 ICUs.
During October 2014, the IPREA questionnaire is administered to all potentially eligible
patients hospitalized in the 34 participating ICUs without applying the program (period P1).
The 17 ICUs of the group 1 do not apply the multicomponent program during 5 months (until
March 2015), while the 17 ICUs of the group 2 apply the program (period P2). During April
2015, the questionnaire IPREA is administered again in both groups (period P3). From May
2015 until September 2015, the multicomponent program is only applied in the group 1 and no
longer in the group 2 (period P4) in order to achieve the crossover of the intervention.
During October 2015, the questionnaire IPREA is administered again in both groups (period
P5).
The overall score of discomfort and the scores for each item will be compared in the control
arm and in the interventional arm.
The control arm consists in the patients included in the group 2 during October 2014 and the
patients included in the group 1 during April 2015, i.e. patients included during the month
preceding the implementation of the multicomponent program.
The interventional arm consists in the patients included in the group 2 during April 2015
and the patients included in the group 1 during October 2015, i.e. patients included during
the last month of the period of application of the multicomponent program.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Completed |
NCT03671447 -
Enhanced Recovery After Intensive Care (ERIC)
|
N/A | |
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Completed |
NCT04239209 -
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
|
N/A | |
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT02916004 -
The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Completed |
NCT04479254 -
The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study)
|
N/A | |
Recruiting |
NCT04475666 -
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
|
N/A | |
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Recruiting |
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Completed |
NCT02899208 -
Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?
|
N/A | |
Recruiting |
NCT02163109 -
Oxygen Consumption in Critical Illness
|